After receiving 55 applications in 2017 for their first ever accelerator program, ANDHealth has selected 6 mid-stage digital health companies to receive support in progressing their technology towards investment and reaching global markets. Resources are provided in the form of time and resources from expert advisors, media and communications training, intellectual property advice, access to $60,000 of project funds and a global network of digital health experts.

The digital health initiative, ANDHealth, was established by a consortium of commercial and government partners, led by the Murdoch Children’s Research Institute, and focuses on the development and commercialisation of validated digital health projects across Australia. The project is supported by Australian Industry Growth Centre, MTPConnect.

“We were genuinely overwhelmed by the number and quality of applications, given our focus is on companies that are already well down the product development pathway,” said ANDHealth Managing Director, Bronwyn Le Grice.

“The exceptional quality of the first cohort of companies is a clear indication of the global potential of our digital health sector and we are delighted to be working with such innovative and dynamic teams.”

The first cohort includes the following companies:

DoseMe – A precision medicine dosing platform which improves dosing accuracy and patient outcomes through real-time medication dosing decision support.

Human Gas Capsule – A connected electronic pill sensor which provides real time gas information for gut health diagnosis and management.

Perx – A digital intervention for changing the way people and healthcare organisations approach medication adherence which forms positive habits through fun games and memorable rewards.

Seer Medical – A wearable device and cloud computing technology which delivers hospital standard epilepsy monitoring and diagnosis in the home.

SkinView – A point of care solution for diagnosis of skin cancer and skin lesions which transforms a smartphone into a diagnostic dermatoscope.

PenPal – A digital allergy tool which empowers temporary carers of children with allergies through on the spot access to life saving personalised information and treatment steps.

Share this: